Ten years ago, Sajith Wickramasekara dropped out of the Computer Science program at MIT to build something new: a software company that helps life science researchers better organize their lab work.

How scientists are using Benchling AI in Claude today. Building the AI ecosystem for biotech AI's potential for impact in life sciences is profound. As Anthropic CEO Dario Amodei has said in his ...

SAN FRANCISCO and BOSTON, May 7, 2025 /CNW/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling supporting ...

Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...

SAN FRANCISCO, June 11, 2025 /PRNewswire/ -- Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a software framework that helps ...

Benchling, which develops software tools for scientists and pharmaceutical research organizations, has laid off 74 employees, or 9 per cent of its workforce, its spokesperson confirmed on Friday. The ...

:Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...

Benchling has announced it closed $50 million in Series D funding led by Alkeon and joined by new investors Spark Capital, Lux Capital and ICONIQ Partners, as well as existing investors Thrive Capital ...